M. Herranz

674 total citations
8 papers, 564 citations indexed

About

M. Herranz is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, M. Herranz has authored 8 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in M. Herranz's work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers) and Ubiquitin and proteasome pathways (2 papers). M. Herranz is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers) and Ubiquitin and proteasome pathways (2 papers). M. Herranz collaborates with scholars based in Spain. M. Herranz's co-authors include Mario F. Fraga, Manel Esteller, Esteban Ballestar, José Manuel González‐Sancho, J.M. Jurado, Jesús Espada, Maria F. Paz, Alberto Múñoz, Óscar Aguilera and José Fernández‐Piqueras and has published in prestigious journals such as Oncogene, Carcinogenesis and Leukemia.

In The Last Decade

M. Herranz

8 papers receiving 557 citations

Peers

M. Herranz

MB

ONCOL

CR

PFM

GENET

Zhi-Ren Liu United States

Zamir Brelvi United States

Hideki Kakiuchi Japan

Sue Penrhyn-Lowe United Kingdom

Qingyi Wei United States

S. Majewski Poland

Katarzyna Kiwerska Poland

Mary A. Mallon United States

L.-M. Parvinen Finland

Yi Young Choi South Korea

Zhi-Ren Liu United States

M. Herranz

516 ×1.2

MB

159 ×1.0

ONCOL

96 ×1.1

CR

32 ×0.4

PFM

31 ×0.5

GENET

Citations per year, relative to M. Herranz M. Herranz (= 1×) peers Zhi-Ren Liu

Countries citing papers authored by M. Herranz

Since Specialization

Citations

This map shows the geographic impact of M. Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Herranz more than expected).

Fields of papers citing papers by M. Herranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Herranz. The network helps show where M. Herranz may publish in the future.

Co-authorship network of co-authors of M. Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Herranz. A scholar is included among the top collaborators of M. Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Herranz. M. Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sánchez, A., Fernando Setién, Natalia J. Martinez, et al.. (2008). Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas. Oncogene. 27(36). 4969–4972. 22 indexed citations

2.

Mulero‐Navarro, Sonia, José María Carvajal-González, M. Herranz, et al.. (2006). The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis. 27(5). 1099–1104. 89 indexed citations

3.

García‐Cao, Isabel, M. Herranz, Pilar López, et al.. (2006). Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma. Oncogene. 25(29). 4128–4132. 63 indexed citations

4.

Aguilera, Óscar, Mario F. Fraga, Esteban Ballestar, et al.. (2006). Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 25(29). 4116–4121. 296 indexed citations

5.

Herranz, M., Miguel Urioste, Javier Santos, et al.. (1999). Analysis of the INK4a/ARF locus in non-Hodgkin’s lymphomas using two new internal microsatellite markers. Leukemia. 13(5). 808–810. 16 indexed citations

6.

Herranz, M., et al.. (1999). Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas.. PubMed. 59(9). 2068–71. 30 indexed citations

7.

Santos, Javíer, Ignacío Pérez de Castro, M. Herranz, Àngel Pellicer, & José Fernández‐Piqueras. (1996). Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas.. PubMed. 12(3). 669–76. 43 indexed citations

8.

Santos, Javíer, Ignacío Pérez de Castro, M. Herranz, & José Fernández‐Piqueras. (1995). Eight new polymorphic microsatellites in mouse gene loci. Cytogenetic and Genome Research. 71(3). 223–224. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact